Overview

Study Evaluating the Pharmacokinetics of Tigecycline in Human Bone

Status:
Completed
Trial end date:
2008-10-01
Target enrollment:
Participant gender:
Summary
Study to examine the concentration of the study drug, tigecycline, in human bone samples following the administration of multiple doses.
Phase:
Phase 1
Details
Lead Sponsor:
Wyeth is now a wholly owned subsidiary of Pfizer
Treatments:
Minocycline
Tigecycline